KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Total Current Liabilities (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Total Current Liabilities data on record, last reported at $1.8 billion in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 20.5% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $1.8 billion, up 20.5%, while the annual FY2025 figure was $1.8 billion, 20.5% up from the prior year.
  • Total Current Liabilities reached $1.8 billion in Q4 2025 per EW's latest filing, up from $1.4 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.9 billion in Q3 2024 and bottomed at $799.0 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: fell 5.03% in 2022, then soared 56.92% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $1.0 billion in 2021, then fell by 0.96% to $1.0 billion in 2022, then increased by 16.92% to $1.2 billion in 2023, then grew by 25.92% to $1.5 billion in 2024, then rose by 20.5% to $1.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $1.8 billion in Q4 2025, $1.4 billion in Q1 2025, and $1.5 billion in Q4 2024.